Compare BLLN & UBSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BLLN | UBSI |
|---|---|---|
| Founded | 2016 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.0B | 5.2B |
| IPO Year | 2025 | N/A |
| Metric | BLLN | UBSI |
|---|---|---|
| Price | $100.35 | $38.16 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 6 | 3 |
| Target Price | ★ $138.67 | $41.83 |
| AVG Volume (30 Days) | 270.6K | ★ 624.7K |
| Earning Date | 12-09-2025 | 01-23-2026 |
| Dividend Yield | N/A | ★ 3.88% |
| EPS Growth | N/A | ★ 15.26 |
| EPS | N/A | ★ 3.05 |
| Revenue | $209,032,000.00 | ★ $1,127,073,000.00 |
| Revenue This Year | N/A | $23.91 |
| Revenue Next Year | N/A | $4.64 |
| P/E Ratio | ★ N/A | $12.50 |
| Revenue Growth | ★ 112.72 | 11.50 |
| 52 Week Low | $88.00 | $30.51 |
| 52 Week High | $138.70 | $42.40 |
| Indicator | BLLN | UBSI |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 61.79 |
| Support Level | N/A | $34.68 |
| Resistance Level | N/A | $38.13 |
| Average True Range (ATR) | 0.00 | 0.79 |
| MACD | 0.00 | 0.20 |
| Stochastic Oscillator | 0.00 | 98.02 |
BillionToOne Inc is a precision diagnostics company revolutionizing molecular testing with its patented Quantitative Counting Templates (QCT) platform. This technology enables ultrasensitive, single-molecule DNA quantification, making genetic testing more accurate, affordable, and accessible. The company serves prenatal screening and oncology markets with non-invasive tests that detect fetal genetic risks and monitor cancer therapy response.
United Bankshares Inc is a financial holding company that provides banking services. The company operates in one segment: Community banking, which accepts deposits, makes loans (for personal, credit card, commercial, and construction uses), provides brokerage services, safe deposit boxes, and related services.